Cynthia Armanda Lawton, MS LMFT | |
6 Franklin St, Westerly, RI 02891-3138 | |
(401) 596-5310 | |
Not Available |
Full Name | Cynthia Armanda Lawton |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 6 Franklin St, Westerly, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053478909 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | MFT00064 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cynthia Armanda Lawton, MS LMFT 6 Franklin St, Westerly, RI 02891-3138 Ph: (401) 596-5310 | Cynthia Armanda Lawton, MS LMFT 6 Franklin St, Westerly, RI 02891-3138 Ph: (401) 596-5310 |
News Archive
When reaching into a pocket or purse, it is easy to use the sense of touch to distinguish keys from loose change. Our brains seamlessly integrate the tactile, sensory cues from our fingers with hand movements to perceive the different objects.
Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership. Existing investor CSV Capital Partners will also participate in the financing. The financing will be used primarily to enhance Realton's marketing and distribution networks, expand its manufacturing capabilities and pursue new technology development.
NewYork-Presbyterian Hospital, along with its affiliated medical schools Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, announced its collaboration with the New York Center for Autism to establish the Institute for Brain Development, a comprehensive, state-of-the-art institute dedicated to addressing the pressing clinical needs of individuals living with autism spectrum disorders and other developmental disorders of the brain, across their lifespan.
Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP).
› Verified 2 days ago
Paulette L Chamberas, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 85 Beach St, Westerly, RI 02891 Phone: 401-369-1178 |